SIRT1 and other sirtuins in metabolism

Trends in Endocrinology and Metabolism

Volumn 25, Issue 3, 2014, Pages 138-145

  Chang, Hung Chun ^a   Guarente, Leonard ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Aging; Calorie restriction; CR mimetics; Metabolism; NAD+; SIRT1; Sirtuins

Indexed keywords

AGING; CALORIE RESTRICTION; CR MIMETICS; METABOLISM; NAD(+); SIRT1; SIRTUINS;

ADIPOSE TISSUE; AGING; ANIMALS; HUMANS; LIVER; SIRTUIN 1; SIRTUINS;

EID: 84894352303     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.12.001     Document Type: Review

References (120)

1. Imai S., et al. Transcriptional silencing and longevity protein sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
2. Klar A.J., et al. Mar1-a regulator of the hma and hmalpha loci in Saccharomyces cerevisiae. Genetics 1979, 93:37-50.
3. Sinclair D.A., Guarente L. Extrachromosomal rdna circles--a cause of aging in yeast. Cell 1997, 91:1033-1042.
4. Kaeberlein M., et al. The sir2/3/4 complex and sir2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999, 13:2570-2580.
5. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in caenorhabditis elegans. Nature 2001, 410:227-230.
6. Viswanathan M., Guarente L. Regulation of caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature 2011, 477:E1-E2.
7. Rogina B., Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15998-16003.
8. Lin S.J., et al. Requirement of NAD and sir2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000, 289:2126-2128.
9. Lin S.J., et al. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 2002, 418:344-348.
10. Anderson R.M., et al. Yeast life-span extension by calorie restriction is independent of nad fluctuation. Science 2003, 302:2124-2126.
11. Burnett C., et al. Absence of effects of sir2 overexpression on lifespan in C. elegans and drosophila. Nature 2011, 477:482-485.
12. Kanfi Y., et al. The sirtuin sirt6 regulates lifespan in male mice. Nature 2012, 483:218-221.
13. Satoh A., et al. Sirt1 extends life span and delays aging in mice through the regulation of nk2 homeobox 1 in the dmh and lh. Cell Metab. 2013, 18:416-430.
14. Guarente L. Calorie restriction and sirtuins revisited. Genes Dev. 2013, 27:2072-2085.
15. Dryden S.C., et al. Role for human sirt2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 2003, 23:3173-3185.
16. Vaquero A., et al. Sirt2 is a histone deacetylase with preference for histone h4 lys 16 during mitosis. Genes Dev. 2006, 20:1256-1261.
17. Serrano L., et al. The tumor suppressor sirt2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of h4k20 methylation. Genes Dev. 2013, 27:639-653.
18. Verdin E., et al. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 2010, 35:669-675.
19. Chalkiadaki A., Guarente L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat. Rev. Endocrinol. 2012, 8:287-296.
20. Kaeberlein M., et al. Saccharomyces cerevisiae ssd1-v confers longevity by a sir2p-independent mechanism. Genetics 2004, 166:1661-1672.
21. Bishop N.A., Guarente L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 2007, 447:545-549.
22. Kenyon C. A pathway that links reproductive status to lifespan in Caenorhabditis elegans. Ann. N. Y. Acad. Sci. 2010, 1204:156-162.
23. Johnson S.C., et al. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493:338-345.
24. Kahn B.B., et al. Amp-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
25. Cohen H.Y., et al. Calorie restriction promotes mammalian cell survival by inducing the sirt1 deacetylase. Science 2004, 305:390-392.
26. Lombard D.B., et al. Mammalian sir2 homolog sirt3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27:8807-8814.
27. Nakagawa T., et al. Sirt5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
28. Civitarese A.E., et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007, 4:e76.
29. Chalkiadaki A., Guarente L. High-fat diet triggers inflammation-induced cleavage of sirt1 in adipose tissue to promote metabolic dysfunction. Cell Metab. 2012, 16:180-188.
30. Pedersen S.B., et al. Low sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int. J. Obes. 2008, 32:1250-1255.
31. Costa Cdos S., et al. Sirt1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. Obes. Surg. 2010, 20:633-639.
32. Chen D., et al. Increase in activity during calorie restriction requires sirt1. Science 2005, 310:1641.
33. Cohen D.E., et al. Neuronal sirt1 regulates endocrine and behavioral responses to calorie restriction. Genes Dev. 2009, 23:2812-2817.
34. Boily G., et al. Sirt1 regulates energy metabolism and response to caloric restriction in mice. PLoS ONE 2008, 3:e1759.
35. Mercken E.M., et al. Sirt1 but not its increased expression is essential for lifespan extension in caloric restricted mice. Aging Cell 2013, 10.1111/acel.12151.
36. Someya S. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812.
37. Hallows W.C., et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 2011, 41:139-149.
38. Baur J.A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
39. Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating sirt1 and pgc-1alpha. Cell 2006, 127:1109-1122.
40. Bordone L., et al. Sirt1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007, 6:759-767.
41. Pfluger P.T., et al. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9793-9798.
42. Herranz D., et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 2010, 1:3.
43. Biason-Lauber A., et al. Identification of a sirt1 mutation in a family with type 1 diabetes. Cell Metab. 2013, 17:448-455.
44. Howitz K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
45. Milne J.C., et al. Small molecule activators of sirt1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 450:712-716.
46. Lam Y.Y., et al. Resveratrol vs. calorie restriction: data from rodents to humans. Exp. Gerontol. 2013, 48:1018-1024.
47. Barger J.L., et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 2008, 3:e2264.
48. Hubbard B.P., et al. Evidence for a common mechanism of sirt1 regulation by allosteric activators. Science 2013, 339:1216-1219.
49. Wood J.G., et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
50. Berdichevsky A., et al. C. elegans sir-2.1 interacts with 14-3-3 proteins to activate daf-16 and extend life span. Cell 2006, 125:1165-1177.
51. Rizki G., et al. The evolutionarily conserved longevity determinants hcf-1 and sir-2.1/sirt1 collaborate to regulate daf-16/foxo. PLoS Genet. 2011, 7:e1002235.
52. Stumpferl S.W., et al. Natural genetic variation in yeast longevity. Genome Res. 2012, 22:1963-1973.
53. Ludewig A.H., et al. Pheromone sensing regulates caenorhabditis elegans lifespan and stress resistance via the deacetylase sir-2.1. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5522-5527.
54. Mouchiroud L., et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial upr and foxo signaling. Cell 2013, 154:430-441.
55. Banerjee K.K., et al. Dsir2 in the adult fat body, but not in muscles, regulates life span in a diet-dependent manner. Cell Rep. 2012, 2:1485-1491.
56. Liu Y., et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008, 456:269-273.
57. Rodgers J.T., et al. Nutrient control of glucose homeostasis through a complex of pgc-1alpha and sirt1. Nature 2005, 434:113-118.
58. Purushotham A., et al. Hepatocyte-specific deletion of sirt1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009, 9:327-338.
59. Hallows W.C., et al. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by sirt1 protein-mediated deacetylation. J. Biol. Chem. 2012, 287:3850-3858.
60. Zhong L., et al. The histone deacetylase sirt6 regulates glucose homeostasis via hif1alpha. Cell 2010, 140:280-293.
61. Kim H.S., et al. Hepatic-specific disruption of sirt6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010, 12:224-236.
62. Horton J.D., et al. SREBPS: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
63. Walker A.K., et al. Conserved role of sirt1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator srebp. Genes Dev. 2010, 24:1403-1417.
64. Li X., et al. Sirt1 deacetylates and positively regulates the nuclear receptor lxr. Mol. Cell 2007, 28:91-106.
65. Kemper J.K., et al. Fxr acetylation is normally dynamically regulated by p300 and sirt1 but constitutively elevated in metabolic disease states. Cell Metab. 2009, 10:392-404.
66. Lee J., et al. A pathway involving farnesoid x receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microrna-34a inhibition. J. Biol. Chem. 2010, 285:12604-12611.
67. Tao R., et al. Hepatic srebp-2 and cholesterol biosynthesis are regulated by foxo3 and sirt6. J. Lipid Res. 2013, 54:2745-2753.
68. Elhanati S., et al. Multiple regulatory layers of srebp1/2 by sirt6. Cell Rep. 2013, 4:905-912.
69. Asher G., et al. Sirt1 regulates circadian clock gene expression through per2 deacetylation. Cell 2008, 134:317-328.
70. Nakahata Y., et al. The NAD+-dependent deacetylase sirt1 modulates clock-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340.
71. Hirschey M.D., et al. Sirt3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
72. Shimazu T., et al. Sirt3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl coa synthase 2 and regulates ketone body production. Cell Metab. 2010, 12:654-661.
73. Nasrin N., et al. Sirt4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 2010, 285:31995-32002.
74. Laurent G., et al. Sirt4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation. Mol. Cell. Biol. 2013, 33:4552-4561.
75. Gerhart-Hines Z., et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through sirt1/pgc-1alpha. EMBO J. 2007, 26:1913-1923.
76. Hardie D.G., et al. Ampk: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
77. Jager S., et al. Amp-activated protein kinase (ampk) action in skeletal muscle via direct phosphorylation of pgc-1alpha. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12017-12022.
78. Fulco M., et al. Glucose restriction inhibits skeletal myoblast differentiation by activating sirt1 through ampk-mediated regulation of nampt. Dev. Cell 2008, 14:661-673.
79. Canto C., et al. AMPK regulates energy expenditure by modulating nad+ metabolism and sirt1 activity. Nature 2009, 458:10561060.
80. Lan F., et al. Sirt1 modulation of the acetylation status, cytosolic localization, and activity of lkb1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 2008, 283:27628-27635.
81. Jing E., et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 2013, 62:3404-3417.
82. Iwabu M., et al. Adiponectin and adipor1 regulate pgc-1alpha and mitochondria by ca(2+) and ampk/sirt1. Nature 2010, 464:1313-1319.
83. Picard F., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing ppar-gamma. Nature 2004, 429:771-776.
84. Qiang L., et al. Brown remodeling of white adipose tissue by sirt1-dependent deacetylation of ppargamma. Cell 2012, 150:620-632.
85. Mattagajasingh I., et al. Sirt1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14855-14860.
86. Shinmura K., et al. Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear sirt1. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2348-H2355.
87. Planavila A., et al. Sirt1 acts in association with pparalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc. Res. 2011, 90:276-284.
88. Alcendor R.R., et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 2007, 100:1512-1521.
89. Pillai V.B., et al. Exogenous nad blocks cardiac hypertrophic response via activation of the sirt3-lkb1-amp-activated kinase pathway. J. Biol. Chem. 2010, 285:3133-3144.
90. Sundaresan N.R., et al. The sirtuin sirt6 blocks igf-akt signaling and development of cardiac hypertrophy by targeting c-jun. Nat. Med. 2012, 18:1643-1650.
91. Vakhrusheva O., et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 2008, 102:703-710.
92. Ramadori G., et al. Brain sirt1: Anatomical distribution and regulation by energy availability. J. Neurosci. 2008, 28:9989-9996.
93. Satoh A., et al. Sirt1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. J. Neurosci. 2010, 30:10220-10232.
94. Ramadori G., et al. Sirt1 deacetylase in pomc neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab. 2010, 12:78-87.
95. Ramadori G., et al. Sirt1 deacetylase in sf1 neurons protects against metabolic imbalance. Cell Metab. 2011, 14:301-312.
96. Sasaki T., et al. Induction of hypothalamic sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology 2010, 151:2556-2566.
97. Velasquez D.A., et al. The central sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes 2011, 60:1177-1185.
98. Lu M., et al. Neuronal sirt1 deficiency increases insulin sensitivity in both brain and peripheral tissues. J. Biol. Chem. 2013, 288:10722-10735.
99. Chang H.C., Guarente L. Sirt1 mediates central circadian control in the scn by a mechanism that decays with aging. Cell 2013, 153:1448-1460.
100. Firestein R., et al. The sirt1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE 2008, 3:e2020.
101. Wang R.H., et al. Impaired DNA damage response, genome instability, and tumorigenesis in sirt1 mutant mice. Cancer Cell 2008, 14:312-323.
102. Kim H.S., et al. Sirt2 maintains genome integrity and suppresses tumorigenesis through regulating apc/c activity. Cancer Cell 2011, 20:487-499.
103. Finley L.W., et al. Sirt3 opposes reprogramming of cancer cell metabolism through hif1alpha destabilization. Cancer Cell 2011, 19:416-428.
104. Jeong S.M., et al. Sirt4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 2013, 23:450-463.
105. Sebastian C., et al. The histone deacetylase sirt6 is a tumor suppressor that controls cancer metabolism. Cell 2012, 151:1185-1199.
106. Kim H.S., et al. Sirt3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
107. Guo X., et al. Dyrk1a and dyrk3 promote cell survival through phosphorylation and activation of sirt1. J. Biol. Chem. 2010, 285:13223-13232.
108. Gerhart-Hines Z., et al. The camp/pka pathway rapidly activates sirt1 to promote fatty acid oxidation independently of changes in NAD(+). Mol. Cell 2011, 44:851-863.
109. Kim J.E., et al. Dbc1 is a negative regulator of sirt1. Nature 2008, 451:583-586.
110. Escande C., et al. Deleted in breast cancer-1 regulates sirt1 activity and contributes to high-fat diet-induced liver steatosis in mice. J. Clin. Invest. 2010, 120:545-558.
111. Lin S.J., et al. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 2004, 18:12-16.
112. Ramsey K.M., et al. Age-associated loss of sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific sirt1-overexpressing (besto) mice. Aging Cell 2008, 7:78-88.
113. Yoshino J., et al. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011, 14:528-536.
114. Canto C., et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012, 15:838-847.
115. Schmeisser K., et al. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat. Chem. Biol. 2013, 9:693-700.
116. Bai P., et al. Parp-1 inhibition increases mitochondrial metabolism through sirt1 activation. Cell Metab. 2011, 13:461-468.
117. Ramsey K.M., et al. Circadian clock feedback cycle through nampt-mediated nad+ biosynthesis. Science 2009, 324:651-654.
118. Nakahata Y., et al. Circadian control of the nad+ salvage pathway by clock-sirt1. Science 2009, 324:654-657.
119. Peek C.B., et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 2013, 342:1243417.
120. Dai H., et al. Sirt1 activation by small molecules: Kinetic and biophysical evidence for direct interaction of enzyme and activator. J. Biol. Chem. 2010, 285:32695-32703.